Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7206)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 25, 2022 (publication date) through Jan 12, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Virology
ISSN
2220-3249
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Panayiotakopoulos GD, Papadimitriou DT. Rifampicin for COVID-19. World J Virol 2022; 11(2): 90-97 [PMID: 35433334 DOI: 10.5501/wjv.v11.i2.90] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Panayiotakopoulos GD, Papadimitriou DT. Rifampicin for COVID-19. World J Virol 2022; 11(2): 90-97 [PMID: 35433334 DOI: 10.5501/wjv.v11.i2.90] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i2/90.htm |
| Number | Citing Articles |
| 1 |
Marwa El-Azazy, Ahmed S. El-Shafie, Reem Al-Mulla, Siham S. Hassan, Hassan I. Nimir. Enhanced adsorptive removal of rifampicin and tigecycline from single system using nano-ceria decorated biochar of mango seed kernel. Heliyon 2023; 9(5): e15802 doi: 10.1016/j.heliyon.2023.e15802
|
| 2 |
Ozlem Celik Aydin, Sonay Aydın, Sureyya Barun. Possible agent for COVID-19 treatment: Rifampicin. World Journal of Virology 2022; 11(5): 391-393 doi: 10.5501/wjv.v11.i5.391
Abstract(767) |
Core Tip(817) |
Full Article(HTML)(2410)
|
Full Article (PDF)-567K(228)
|
Full Article (Word)-105K(40)
|
Audio-48K(9)
|
Peer-Review Report-227K(135)
|
Answering Reviewers-76K(133)
|
Times Cited (0)
|
Total Visits (7876)
|
Open
|
| 3 |
Bhoomika Patel, Anita Sinha, Mamatarani Verma, Dhwani Patel, Jigar Desai. A Study of COVID-19 Infected Patients with Tuberculosis as Comorbidity and on Antitubercular Drug Therapy. Indian Journal of Respiratory Care 2023; 12(3): 239 doi: 10.5005/jp-journals-11010-1058
|
| 4 |
Gabrielle Haas, Mélodie Seiler, Jenny Nguyen, Laurent Troxler, Samuel Pennarun, Elise Lefebvre, Yasmine Benamrouche, Loriane Loizeau, Cody Reinbolt, Ming Liang, Xiaoliang Lin, Wenzhi Li, Zumeng Xia, Joao T. Marques, Jean-Luc Imler. Regulation of detoxifying enzymes expression and restriction of picorna-like virus infection by natural polysaccharide extracts in Drosophila cells. Virology 2025; 607: 110513 doi: 10.1016/j.virol.2025.110513
|
| 5 |
By Lina Amrani, Nurin Sabrina Zawari, Nur Zahirah Afrina Abd Rahman, Adzzie Shazleen Azman, Nurshamimi Nor Rashid, Jasmine Elanie Khairat. Unlocking nature's hidden treasures: Actinomycetota's arsenal of potent antiviral compounds against human viral infections. Microbial Pathogenesis 2025; 208: 107953 doi: 10.1016/j.micpath.2025.107953
|
| 6 |
Vasyl Popovych, Ivanna Koshel, Nataly Bezdetko, Andrii Volianskyi. THE ROLE OF MICROBIOME CHANGES IN THE FORMATION OF CHRONIC INFLAMMATORY DISEASES OF THE UPPER RESPIRATORY TRACT AND THE POTENTIAL OF TOPICAL ANTIBIOTICS IN THEIR CORRECTION. ANALYTICAL REVIEW. OTORHINOLARYNGOLOGY 2025; 8(3-4): 62 doi: 10.37219/2528-8253-2025-3-4-62
|
| 7 |
Jasmine Arya, Sweety Dahiya, Anil Kumar Chhillar. Multidrug-resistant Tuberculosis and its Implication with COVID-19. Coronaviruses 2023; 4(3) doi: 10.2174/2666796704666230822113632
|
| 8 |
Khaled Abo-EL-Sooud, Hagar Hesham, Maryam Saeed, Sarah Mohamed, Fady Sayed Youssef. Combined in vivo and silico assessment of melatonin’s protective effects on rifampicin-induced liver damage in rats. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-16453-z
|